GGrantIndex
Sort

11,323 grants matching glioblastoma

Glioblastoma stem cells therapy

$361,200
Bakhos A. Tannous · Massachusetts General Hospital · R01 · FY2015 · NS

Targeting Refractory EGFR-Driven Tumors By Induction Of Dominant-Negative EGFR Splicing Variants

$361,147
Luca Cartegni · Rutgers, The State Univ Of N.J. · R01 · FY2020 · CA

Polyamine Catabolism and Therapeutic Resistance in Glioblastoma Multiforme

$361,136
Scott Michael Welford · Case Western Reserve University · R01 · FY2016 · CA

Computational and Experimental Modeling of Alternative Polyadenylation

$361,128
Wei Li · Baylor College Of Medicine · R01 · FY2018 · CA

Computational and Experimental Modeling of Alternative Polyadenylation

$361,128
Wei Li · Baylor College Of Medicine · R01 · FY2017 · CA

OVERCOMING LOCAL AND PERIPHERAL IMMUNE SUPPRESSION IN GLIOMA TO FACILITATE EFFEC

$361,125
Andrew T Parsa · University Of California, San Francisco · P50 · FY2017 · CA

P38 MAPK is a molecular switch that controls the acquired resistance in adoptive cell therapy

$361,117
Yong Lu · Methodist Hospital Research Institute · R37 · FY2023 · CA

Core 2: Genomics/Epigenomics Sequencing Core

$361,057
Jacek Majewski · Rockefeller University · P01 · FY2015 · CA

Tumor Microenvironment in Modulating the Primary & Metastatic Brain Tumors

$361,019
Johanna Joyce · Sloan-Kettering Inst Can Research · U54 · FY2008 · CA

RNAi screen of the glioblastoma stem cell kinome under hypoxia and normoxia

$360,938
Brent H. Cochran · Tufts University Boston · R01 · FY2012 · NS

RNAi screen of the glioblastoma stem cell kinome under hypoxia and normoxia

$360,938
Brent H. Cochran · Tufts University Boston · R01 · FY2011 · NS

RNAi screen of the glioblastoma stem cell kinome under hypoxia and normoxia

$360,938
Brent H. Cochran · Tufts University Boston · R01 · FY2015 · NS

Analyzing Adhesion and Signaling Functions for PTPN12 in Invasive Glioma Cells

$360,856
Joseph H McCarty · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · NS

Molecular Motors and Glioma Dispersion

$360,785
Steven S Rosenfeld · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · NS

Intracellular Host Tumor Responses to oHSVs and Avenues to Overcome These

$360,760
E. Antonio Chiocca · Ohio State University · P01 · FY2014 · CA

SON-mediated RNA splicing in glioblastoma

$360,701
Erin Eun-Young Ahn · University Of Alabama At Birmingham · R01 · FY2020 · CA

Interaction between Tissue Factor, Junctional Adhesion Molecule-A, and Integrin B1 to drive self-renewal in glioblastoma

$360,687
Craig Michael Horbinski · Northwestern University At Chicago · R01 · FY2021 · NS

Reprogramming the tumormicroenvironment to improve immunotherapy of glioblastoma

$360,653
Rakesh K. Jain · Massachusetts General Hospital · R01 · FY2024 · CA

Metabolic interactions between tumor cells and the immunce system in GBM A potential Achilles heel of GBM for novel therapeutics

$360,522
Loic Pierre Deleyrolle · University Of Florida · R01 · FY2024 · NS

The Role of Caspase-8 in Neuroblastoma Tumorigenesis

$360,423
Gerard Paul Zambetti · St. Jude Children'S Research Hospital · R01 · FY2013 · CA

Genetic Dissection of Glioblastoma: Cell of Origin

$360,388
Robert M Bachoo · Ut Southwestern Medical Center · R01 · FY2010 · NS

KDM1A inhibitors as novel therapeutics for glioblastoma

$360,380
Gangadhara R Sareddy · University Of Texas Hlth Science Center · R01 · FY2021 · NS

Novel adhesion mechanisms in glioblastoma stem cells

$360,361
Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · R01 · FY2013 · NS

Systemic RNA interference to reactivate p53 tumor suppression

$360,354
Alexander H. Stegh · Northwestern University At Chicago · R01 · FY2017 · CA

Computational and Experimental Modeling of Alternative Polyadenylation

$360,307
Wei Li · University Of California-Irvine · R01 · FY2025 · CA